ETF Holdings Breakdown of MIRM

Stock NameMirum Pharmaceuticals Inc
TickerMIRM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6047491013

News associated with MIRM

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) PT at $58.20
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given an average recommendation of “Buy” by the eleven ratings firms that are covering the stock, Marketbeat reports. Ten research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […] - 2025-04-22 05:34:59
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $58.20 Consensus Target Price from Analysts
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have earned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price […] - 2025-03-28 05:34:46
AlphaQuest LLC Grows Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
AlphaQuest LLC increased its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 969.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,829 shares of the company’s stock after acquiring an additional 1,658 shares during the quarter. AlphaQuest LLC’s holdings in […] - 2025-03-20 08:04:50
Bank of New York Mellon Corp Has $5.14 Million Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Bank of New York Mellon Corp grew its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 8.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 124,328 shares of the company’s stock after acquiring an additional 9,629 shares during the period. Bank of New York Mellon Corp’s holdings in Mirum Pharmaceuticals were […] - 2025-03-18 07:09:03
Empowered Funds LLC Invests $1.38 Million in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Empowered Funds LLC acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 33,266 shares of the company’s stock, valued at approximately $1,376,000. A number of other large investors […] - 2025-02-17 08:16:48
Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $57.10
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have received a consensus rating of “Buy” from the eleven ratings firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-02-06 06:24:49

MIRM institutional holdings

The following institutional investment holdings of MIRM have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 25,042USD 1,132,900
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 2,933USD 132,689 8.9%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 23,463USD 1,061,466
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 23,463USD 1,061,466 8.9%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 104USD 4,705
Total =75,005 USD 3,393,226
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.